Rion Inc

Vyriad is a biopharmaceutical company based in Rochester, MN, specializing in the development of innovative oncolytic virus platforms, including VSV and Measles. The company combines its expertise in research and development with manufacturing capabilities to advance clinical programs and foster partnerships in the fight against cancer. With a focus on in vivo platforms and clinical expertise, Vyriad is committed to exploring new frontiers in cancer treatment. Their dedicated team collaborates across various disciplines to drive progress and deliver impactful therapies for patients in need. Generated from the website

Emmyon, Inc. is a biotechnology company based in Rochester, MN, specializing in metabolic health research. They focus on investigating the mechanisms behind muscle atrophy caused by aging, illness, and injury. Using this data, they develop small molecules that enhance muscle strength, mass, and metabolism. One of Emmyon's patented technologies is Ursolic Acid and Tomatidine, which aids in maintaining normal muscle mass and strength. The company is dedicated to finding innovative solutions for muscle health in humans, pets, and production animals. They are at the forefront of creating natural feed additives and pharmaceuticals to combat muscle atrophy, obesity, and type 2 diabetes. Emmyon's commitment to healthy aging extends to pioneering ways to preserve muscle quality and strength during the aging process. Their research also delves into developing products that enhance mobility and quality of life for pets, as well as improving feed additives for livestock production. Emmyon, Inc. continues to make strides in the field of metabolic health with a focus on skeletal muscle well-being. Generated from the website content

RION LLC, a clinical-stage regenerative medicine company based in Rochester, MN, was established in 2017 from the Mayo Clinic Employee Entrepreneurial Program. The company focuses on revolutionizing regenerative medicine by isolating a unique exosome phenotype known as the Purified Exosome Product (PEP) from platelets, which is key to tissue regeneration. Through its proprietary manufacturing process, RION produces PEP, containing trillions of regenerative exosomes, which can be tailored for various clinical applications and administered via multiple routes. RION's commitment to harnessing the regenerative properties of platelets positions it at the forefront of exosome-based therapies, promising significant advancements in healing and tissue repair. Generated from the website